4/A//SEC Filing
Simoneit Diona 4/A
Accession 0001799191-22-000053
CIK 0001799191other
Filed
Nov 21, 7:00 PM ET
Accepted
Nov 22, 8:08 PM ET
Size
5.6 KB
Accession
0001799191-22-000053
Insider Transaction Report
Form 4/AAmended
Simoneit Diona
Chief Accounting OfficerOther
Transactions
- Sale
Common Stock
2022-11-15$2.03/sh−190$385→ 29,318 total
Footnotes (2)
- [F1]This Form 4/A amends and restates the reporting persons Form 4 originally filed on November 17, 2022 in the entirety. This Form 4/A is being filed to correct the reporting persons original Form 4 from Code D to Code S. The sales reported in the Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on November 15, 2022 within a one-dollar range. Actual prices ranged from $2.025 to $2.028. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
Related Parties
1- filerCIK 0001921432
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 21, 7:00 PM ET
- Accepted
- Nov 22, 8:08 PM ET
- Size
- 5.6 KB